Adverse events1,276

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 1,276

Type	Event	Organ system	Group	Affected	At risk	Events
other	Bone marrow hypocellular	Blood and lymphatic system disorders	Phase I - Alemtuzumab and Combination Chemotherapy	2	119	2
other	Bone marrow hypocellular	Blood and lymphatic system disorders	Phase II - Alemtuzumab and Combination Chemotherapy	0	181	0
other	Disseminated intravascular coagulation	Blood and lymphatic system disorders	Phase I - Alemtuzumab and Combination Chemotherapy	7	119	7
other	Disseminated intravascular coagulation	Blood and lymphatic system disorders	Phase II - Alemtuzumab and Combination Chemotherapy	11	181	11
other	Febrile neutropenia	Blood and lymphatic system disorders	Phase I - Alemtuzumab and Combination Chemotherapy	55	119	74
other	Febrile neutropenia	Blood and lymphatic system disorders	Phase II - Alemtuzumab and Combination Chemotherapy	93	181	141
other	Hemoglobin decreased	Blood and lymphatic system disorders	Phase I - Alemtuzumab and Combination Chemotherapy	93	119	352
other	Hemoglobin decreased	Blood and lymphatic system disorders	Phase II - Alemtuzumab and Combination Chemotherapy	150	181	650
other	Lymphatic disorder	Blood and lymphatic system disorders	Phase I - Alemtuzumab and Combination Chemotherapy	2	119	2
other	Lymphatic disorder	Blood and lymphatic system disorders	Phase II - Alemtuzumab and Combination Chemotherapy	1	181	1
other	Spleen disorder	Blood and lymphatic system disorders	Phase I - Alemtuzumab and Combination Chemotherapy	0	119	0
other	Spleen disorder	Blood and lymphatic system disorders	Phase II - Alemtuzumab and Combination Chemotherapy	1	181	1
other	Arrhythmia	Cardiac disorders	Phase I - Alemtuzumab and Combination Chemotherapy	3	119	3
other	Arrhythmia	Cardiac disorders	Phase II - Alemtuzumab and Combination Chemotherapy	1	181	1
other	Atrial fibrillation	Cardiac disorders	Phase I - Alemtuzumab and Combination Chemotherapy	1	119	1
other	Atrial fibrillation	Cardiac disorders	Phase II - Alemtuzumab and Combination Chemotherapy	5	181	9
other	Atrial flutter	Cardiac disorders	Phase I - Alemtuzumab and Combination Chemotherapy	0	119	0
other	Atrial flutter	Cardiac disorders	Phase II - Alemtuzumab and Combination Chemotherapy	1	181	1
other	Atrial tachycardia	Cardiac disorders	Phase I - Alemtuzumab and Combination Chemotherapy	0	119	0
other	Atrial tachycardia	Cardiac disorders	Phase II - Alemtuzumab and Combination Chemotherapy	1	181	1

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00061945/events

API reference For AI assistants

Adverse events1,276

Sources 3

Read this list from software.